Sarcoma trials in Poland
16 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
- Where
- Bystra, Gdansk, Kielce, Olsztyn, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07541170 · EU 2025-524263-21-01 - Phase 3Taking peopleA Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Where
- Cracow, Gorlice, Lublin, Olsztyn, Peremyshl, Warsaw
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06345729 · EU 2023-507776-42-00 - Phase 3Taking peopleFight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
- Where
- Warsaw
- Age
- 4 years and over
- People
- 530 worldwide
- Run by
- Gustave Roussy, Cancer Campus, Grand Paris
See details and how to joinNCT07871864 - No phaseTaking peopleRadiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions
- Where
- Zamość
- Age
- 18 years and over
- People
- 500
- Run by
- Affidea Nu-med Center of Oncological DIagnostics and Therapy
See details and how to joinNCT07883798 - Phase 3Taking peopleInternational Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
- Where
- Warsaw
- Age
- Up to 64 years
- People
- 1,351 worldwide
- Run by
- GPOH gGmbH
See details and how to join2022-501180-40-00 · EU 2022-501180-40-00 - Phase 3Taking peopleSurgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
- Where
- Warsaw
- Age
- 18 years and over
- People
- 250 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04031677 - Phase 2Taking peopleTo Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
- Where
- Warsaw, Wroclaw
- Age
- 2 years to 21 years
- People
- 24
- Run by
- Anna Raciborska
See details and how to joinNCT05968768 - Phase 2Taking peopleEvaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma
- Where
- Warsaw
- Age
- 5 months to 30 years
- People
- 40
- Run by
- Anna Raciborska
See details and how to joinNCT07787429 - Phase 2Taking peopleKEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Where
- Gdansk, Koszalin, Warsaw
- Age
- 18 years and over
- People
- 140 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07252739 · EU 2025-521939-36-00 - Phase 3Taking peopleA Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- Where
- Gdansk, Poznan, Warsaw, Wroclaw
- Age
- 18 years and over
- People
- 333 worldwide
- Run by
- Intensity Therapeutics, Inc.
See details and how to joinNCT06263231 · EU 2024-512423-36-00 - No phaseTaking peopleProspective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
- Where
- Warsaw
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Australia and New Zealand Sarcoma Association
See details and how to joinNCT07377747 - Phase 1/2Taking peopleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- Where
- Gdansk, Warsaw
- Age
- 12 years and over
- People
- 500 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00 - No phaseTaking peopleThe Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
- Where
- Warsaw
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT06408441 - No phaseTaking peopleStereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
- Where
- Gdansk, Warsaw
- Age
- 18 years and over
- People
- 200 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT04498767 - Phase 2Taking peopleTo evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.
- Where
- Warsaw, Wroclaw
- Age
- Up to 64 years
- People
- 24
- Run by
- Instytut Matki I Dziecka
See details and how to join2024-514441-11-00 · EU 2024-514441-11-00 - No phaseTaking peopleREtroperitoneal SArcoma Registry: an International Prospective Initiative
- Where
- Warsaw
- Age
- 18 years and over
- People
- 2,000 worldwide
- Run by
- Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
See details and how to joinNCT03838718